Skip to main content
Equibles

Kenneth L. Waggoner

CEO

Avai Bio, Inc. (AVAI)

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Kenneth L. Waggoner

Kenneth L. Waggoner is recorded as CEO at Avai Bio, Inc. (AVAI). Avai Bio, Inc. reported in an 8-K filed July 15, 2024 that Kenneth L. Waggoner was appointed Chief Executive Officer ("CEO"), effective July 10, 2024. Avai Bio, Inc. reported in an 8-K filed April 28, 2023 that Kenneth L. Waggoner was appointed Chief Executive Officer, effective April 20, 2023. Avai Bio, Inc. reported in an 8-K filed April 24, 2023 that Kenneth L. Waggoner was appointed Chief Executive Officer, effective April 20, 2023.

“On July 10, 2024 (the “Effective Date”), Avant Technologies, Inc. (the “Company” or “Avant”) and Kenneth L. Waggoner entered into an Executive Compensation Agreement (the “Agreement”) pursuant to which Mr. Waggoner was retained as Chief Executive Officer (“CEO”).”
Avai Bio, Inc. Form 8-K, filed July 15, 2024 · Read the filing
“On April 20, 2023, Trend Innovations Holding Inc. (the “Company”) and Kenneth L. Waggoner entered into an Executive Compensation Agreement pursuant to which Mr. Waggoner was retained as Chief Executive Officer.”
Avai Bio, Inc. Form 8-K, filed April 28, 2023 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and call appearances connecting this person to public companies.

Leadership on record at Avai Bio, Inc.

Other people whose current roles at this company are on record from its filings.

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.